JAMA Pediatrics Current Issue
//www.igerbera.com/journals/jamapediatrics
en-us
Wed, 01 Mar 2023 00:00:00 GMT
Mon, 06 Mar 2023 11:43:54 GMT
Silverchair
jamams@jamanetwork.org
support@www.igerbera.com
-
Error in Text
//www.igerbera.com/journals/jamapediatrics/fullarticle/2802241
Wed, 01 Mar 2023 00:00:00 GMT
In the Original Investigation titled “Telehealth Treatment of Behavior Problems in Young Children With Developmental Delay: A Randomized Clinical Trial,” published online January 9, 2023, the Results section of the Abstract and article body incorrectly listed children’s age in years instead of months. This article has been corrected online.
177
3
323
323
10.1001/jamapediatrics.2023.0043
2802241
-
Errors in the Byline and Text
//www.igerbera.com/journals/jamapediatrics/fullarticle/2802240
Wed, 01 Mar 2023 00:00:00 GMT
In the Viewpoint titled “Is There Enough Choline for Children in Food Aid?,” published online January 23, 2023, the second author’s name was misspelled. The correct spelling is Marie Caudill, PhD. In addition, text was updated to reflect minor clarifications. This article was corrected online.
177
3
323
323
10.1001/jamapediatrics.2023.0099
2802240
-
Error in Author Affiliations
//www.igerbera.com/journals/jamapediatrics/fullarticle/2802239
Wed, 01 Mar 2023 00:00:00 GMT
In the Research Letter titled “BNT162b2 Vaccine Effectiveness Against the SARS-CoV-2 Omicron Variant in Children Aged 5 to 11 Years,” published online January 9, 2023, the author affiliations were attributed incorrectly. This article was corrected online.
177
3
323
323
10.1001/jamapediatrics.2023.0205
2802239
-
JAMA Pediatrics
//www.igerbera.com/journals/jamapediatrics/fullarticle/2802221
Wed, 01 Mar 2023 00:00:00 GMT
Vision: JAMA Pediatrics will be the most respected source of information for investigators, providers, and policy makers seeking the highest quality evidence to guide decision-making.
177
3
219
219
10.1001/jamapediatrics.2022.3886
2802221
-
Mental Health in Infants and Young Children
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800781
Wed, 01 Mar 2023 00:00:00 GMT
这个病人描述护理人员如何帮助页p children organize their feelings and emotions to promote mental health.
177
3
324
324
10.1001/jamapediatrics.2022.5715
2800781
-
Autism, Physical Health Conditions, and a Need for Reform
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800780
Wed, 01 Mar 2023 00:00:00 GMT
Currently, 1 in 44 children receive an autism diagnosis by the age of 8 years in the United States; despite improvements in recognition of autism, autistic people still have poor long-term outcomes regarding their health and health care. Overall, autistic people are dying much younger than expected, with several studies now suggesting that autistic people are, on average, dying 12 to 30 years younger than others. Unfortunately, risk of dying by suicide is also elevated among autistic people, with as many as 1 in 3 reporting a previous suicide attempt. However, the growing literature on premature mortality also points to physical health problems that are currently underresearched and underexplored. In particular, there is a paucity of research on the chronic physical health problems among autistic people as they age, with only a handful of studies assessing chronic health burden among those older than 35 years. A new study published in this issue of JAMA Pediatrics by Dhanasekara and colleagues provides important context for clinicians across specialties, as all clinicians will have autistic patients.
177
3
229
230
10.1001 / jamapediatrics.2022.5639
2800780
-
Association Between Autism Spectrum Disorders and Cardiometabolic Diseases
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800779
Wed, 01 Mar 2023 00:00:00 GMT
This systematic review and meta-analysis investigates whether individuals with autism are at a higher associated risk of developing cardiometabolic diseases such as diabetes, hypertension, dyslipidemia, and macrovascular atherosclerotic disease.
177
3
248
257
10.1001/jamapediatrics.2022.5629
2800779
-
Initiation of and Escalation to High-Intensity Drinking in Young Adults
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800778
Wed, 01 Mar 2023 00:00:00 GMT
This cohort study uses survey data of young adults to identify and describe patterns of initiation of and escalation to high-intensity drinking.
177
3
286
293
10.1001/jamapediatrics.2022.5642
2800778
-
Efficacy and Safety of Dietary Therapies for Childhood Drug-Resistant Epilepsy
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800777
Wed, 01 Mar 2023 00:00:00 GMT
This systematic review and network meta-analysis evaluates the comparative efficacy and safety of various dietary therapies in childhood drug-resistant epilepsy.
177
3
258
266
10.1001/jamapediatrics.2022.5648
2800777
-
Associations Between Infant Screen Use, Electroencephalography Markers, and Cognitive Outcomes
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800776
Wed, 01 Mar 2023 00:00:00 GMT
This cohort study analyzes data for children from the population-based study Growing Up in Singapore Toward Healthy Outcomes (GUSTO) to examine the associations between infant screen time, electroencephalography markers, and school-age cognitive outcomes using a mediation analysis.
177
3
311
318
10.1001/jamapediatrics.2022.5674
2800776
-
Produce Prescriptions and a Path Toward Food Equity for Children
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800775
Wed, 01 Mar 2023 00:00:00 GMT
This Viewpoint discusses the benefits of produce prescriptions to support nutrition security and food equity.
177
3
225
226
10.1001/jamapediatrics.2022.5626
2800775
-
Call for Papers on Adolescent Mental Health
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800742
Wed, 01 Mar 2023 00:00:00 GMT
Adolescent mental health is a critical public health issue that is associated with major causes of morbidity and mortality, including suicide. Adolescence is the most vulnerable developmental period for the onset of mental health issues. The incidence of mental disorders peaks between adolescence and young adulthood. Further, the most common mental health issues for youth are increasing. The lifetime prevalence of depression or anxiety among US youth has been reported to increase from 5.4% in 2003 to 8.4% in 2012.
177
3
227
228
10.1001/jamapediatrics.2022.5540
2800742
-
COVID-19 Vaccination During Pregnancy
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800741
Wed, 01 Mar 2023 00:00:00 GMT
To the Editor In their article, Watanabe and colleagues reported that COVID-19 vaccination during pregnancy was not associated with an increased risk of peripartum outcomes and was associated with a decreased risk of neonatal intensive care unit admission, intrauterine fetal death, and maternal SARS-CoV-2 infection.
177
3
322
322
10.1001/jamapediatrics.2022.5392
2800741
-
COVID-19 Vaccination During Pregnancy—Reply
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800740
Wed, 01 Mar 2023 00:00:00 GMT
在回复我们appreciate the interest and comments on our article by Mao. We have demonstrated the possible benefit of COVID-19 vaccination among pregnant individuals by synthesizing published data and showing better peripartum outcomes in those who received vaccination during pregnancy compared with those who did not.
177
3
322
323
10.1001/jamapediatrics.2022.5395
2800740
-
State Expansion of SNAP Eligibility and Rates of Child Protective Services–Investigated Reports
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800739
Wed, 01 Mar 2023 00:00:00 GMT
This cross-sectional study examines the association of expansion of Supplemental Nutrition Assistance Program (SNAP) eligibility by US states with changes in the rates of child protective services–investigated reports for suspected neglect and physical abuse of children.
177
3
294
302
10.1001/jamapediatrics.2022.5348
2800739
-
Association Between Screen Time for Young Children and Neurodevelopmental Outcomes and Mediation by Outdoor Play
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800738
Wed, 01 Mar 2023 00:00:00 GMT
This cohort study analyzes data for young children to investigate the association of higher screen time with neurodevelopmental outcomes and whether this association is mediated by outdoor play.
177
3
303
310
10.1001/jamapediatrics.2022.5356
2800738
-
Is There Enough Choline for Children in Food Aid?
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800737
Wed, 01 Mar 2023 00:00:00 GMT
This Viewpoint discusses food insecurity and the importance of choline-fortified food aid products.
177
3
223
224
10.1001/jamapediatrics.2022.5543
2800737
-
Association Between NICU Type and Care Quality in Preterm Infants
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800549
Wed, 01 Mar 2023 00:00:00 GMT
This cohort study uses national data to evaluate the association between neonatal intensive care unit (NICU) type and care quality in moderate and late preterm infants.
177
3
278
285
10.1001/jamapediatrics.2022.5213
2800549
-
Effectiveness of Intranasal Mometasone Furoate vs Saline for Sleep-Disordered Breathing in Children
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800548
Wed, 01 Mar 2023 00:00:00 GMT
This randomized clinical trial investigates the effectiveness of intranasal mometasone furoate compared with intranasal saline for the treatment of obstructive sleep-disordered breathing in children.
177
3
240
247
10.1001/jamapediatrics.2022.5258
2800548
-
The Need for Tobacco-Related Interventions to Incorporate Digital Media Literacy
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800547
Wed, 01 Mar 2023 00:00:00 GMT
This Viewpoint discusses the need for health promotion programs and interventions to bolster tobacco-related digital media literacy among adolescents, young adults, parents, teachers, and public health organizations.
177
3
221
222
10.1001/jamapediatrics.2022.4970
2800547
-
Coding Error and Errors in Estimates
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800323
Wed, 01 Mar 2023 00:00:00 GMT
The Original Investigation titled “Five-Year Trends in US Children’s Health and Well-being, 2016-2020,” published online March 14, 2022, and in the July issue of JAMA Pediatrics, there were errors in the estimates for one of the measures of interest. A coding error produced shifts in the single-year estimates for preventive medical visits; however, the interpretation and findings of the study were not affected. This article was corrected online, following a previous correction.
177
3
323
323
10.1001/jamapediatrics.2022.5657
2800323
-
在5岁的儿童COVID-19疫苗的有效性to 11 Years
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800322
Wed, 01 Mar 2023 00:00:00 GMT
This cohort study examines data for all children aged 5 to 11 years in South Korea to gauge the effectiveness of the BNT162b2 vaccine when the Omicron variant was the dominant SARS-CoV-2 infection in the country.
177
3
319
320
10.1001/jamapediatrics.2022.5221
2800322
-
The Benefit-Risk Ratio of Late Preterm Antenatal Corticosteroids Could Be Unfavorable in Real-life Situations
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800321
Wed, 01 Mar 2023 00:00:00 GMT
To the Editor As coordinators of the obstetric clinical practice guidelines of the French National College of Gynecologists and Obstetricians (CNGOF), we read with great interest the article of Freret et al reporting increased antenatal corticosteroid (ACS) exposure among US term newborns since the publication of the Antenatal Late Preterm Steroids (ALPS) trial. This trial showed less transient tachypnea of the newborn and shorter use of continuous positive airway pressure in infants exposed to antenatal betamethasone between 34 and 36 completed weeks of gestation compared with those exposed to placebo. The Society for Maternal-Fetal Medicine (SMFM) and the American College of Obstetricians and Gynecologists (ACOG) have then recommended the use of ACS in women at risk of late preterm delivery.
177
3
320
321
10.1001/jamapediatrics.2022.5255
2800321
-
The Benefit-Risk Ratio of Late Preterm Antenatal Corticosteroids Could Be Unfavorable in Real-life Situations—Reply
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800320
Wed, 01 Mar 2023 00:00:00 GMT
在回复我们appreciate the interest of Schmitz et al in our article. As they have noted, even though the Antenatal Late Preterm Steroids trial used stringent criteria to define who was at high risk of preterm birth, more than 15% went on to deliver at term. Similarly, we have shown that clinicians administering late preterm steroids in daily clinical practice in the US may have expanded the use of antenatal steroids to groups with no known benefit, including populations excluded from the original trial (eg, individuals with twin gestations and pregestational diabetes). We hypothesize that the increased exposure among term neonates is likely due to the challenges of predicting preterm birth and more widespread adoption after the publication of the trial and corresponding US professional society clinical guidance documents.
177
3
321
322
10.1001/jamapediatrics.2022.5252
2800320
-
Prenatal and Infant Exposure to Acid-Suppressive Drugs and Allergic Diseases in Children
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800319
Wed, 01 Mar 2023 00:00:00 GMT
This cohort study examines whether prenatal or infant exposure to acid-suppressive medications is associated with increased risk of allergic diseases in children.
177
3
267
277
10.1001/jamapediatrics.2022.5193
2800319
-
Telehealth Treatment of Behavior Problems in Young Children With Developmental Delay
//www.igerbera.com/journals/jamapediatrics/fullarticle/2800318
Wed, 01 Mar 2023 00:00:00 GMT
This randomized clinical trial investigates the effects of an internet-delivered parent-child interaction therapy for children aged 3 years with developmental delay.
177
3
231
239
10.1001/jamapediatrics.2022.5204
2800318